logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

WuXi Biologics to Build New Biologics Plant Near Boston — Announces Four New Facilities (a $792 Million Investment) in Two Months

Jun 12, 2018

Life Science

WuXi AppTec Leads Investment in Insilico, an AI Drug Discovery Company

Jun 12, 2018

Life Science

Translate Bio and Sanofi Ink Potential $850 Million mRNA Vaccine Development Deal

Jun 12, 2018

Life Science

PDTI Preferred Dental Technologies Inc. CSE:PDTI Technology, Medical Device, 牙科,科技,医疗设备

Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI, US OTC: PDTTF): announces partial closing of private placement

Jun 11, 2018

Life Science

A troubling link has been found between a cutting-edge gene-editing technology and cancer — and it’s sending biotech stocks tumbling

Jun 11, 2018

Life Science

Xiangxue to Build Cell-Therapy Manufacturing Plant in Guangzhou;香雪制药将在广州建立细胞疗法生产工厂

Xiangxue to Build Cell-Therapy Manufacturing Plant in Guangzhou

Jun 9, 2018

Life Science

Phil Yang Biological Technology Co., Ltd. and SCIENFOOD Announced the Layout of the Asian Market, China's Big Health Market Pattern will be Rewritten;SCIENFOOD宣布进军亚洲市场,中国保健品市场的格局将被改写

Phil Yang Biological Technology Co., Ltd. and SCIENFOOD Announced the Layout of the Asian Market, China’s Big Health Market Pattern will be Rewritten

Jun 9, 2018

Life Science

RISE Life Science Corp (CSE:RLSC) (formerly Luminor Medical CSE: LMT)

Rise Life Science Provides Operational Update

Jun 8, 2018

Life Science

Resverlogix Announces Withdrawal of Public Offering of Units

Jun 8, 2018

Life Science

Germany-Based Companies Open Lab Space in U.S.

Jun 7, 2018

Life Science

Luye expanding I-O deal with U.S. firm Elpis to focus on CAR T therapies

Jun 7, 2018

Life Science

Oncologie Launches with $16.5 Million for IO Combinations in China and the US

Jun 7, 2018

Life Science

RISE Life Science Corp (CSE:RLSC) (formerly Luminor Medical CSE: LMT)

Rise Life Science Corp. to Acquire California CBD Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind

Jun 7, 2018

Life Science

Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach

Jun 7, 2018

Life Science

Hangzhou Just Biotherapeutics Secures $35 Million Series B+ Financing

Jun 6, 2018

Life Science

Zhejiang Silk Road Joins In $100M Series B Round In British Surgical Robot Developer CMR Surgical

Jun 6, 2018

Life Science

Hookipa Biotech and Gilead Ink Deal to Develop HIV and Hepatitis B Therapies

Jun 5, 2018

Life Science

Tricida Files $150M IPO, Shares Kidney Drug Trial Results

Jun 5, 2018

Life Science

  • ‹‹ Previous
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada